Known colloquially as the bonding hormone, its anxiolytic properties extend far beyond social attachment into direct modulation of fear and anxiety circuits
These exorphins possess all the structural features that are critical for binding these opioid receptors and in turn manifestation of opioid activity (Ul Haq 2020)
[1] Retatrutide (trials): once-weekly subcutaneous administration, starting low (e.g., 2 mg) and escalating to 4, 8, or 12 mg maintenance, with slower titration used to improve tolerability
We offer a topical numbing cream for this procedure
Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk
Documented benefits of DSIP Research has investigated DSIP for numerous applications